Andrew J Tasker, 4112248 Reseda Dr, Yucaipa, CA 92399
Andrew Tasker Phones & Addresses
Yucaipa, CA
6566 Via San Blas, Pleasanton, CA 94566
San Francisco, CA
931 Main St, Fortuna, CA 95540 707-7260163
931 Main St #6, Fortuna, CA 95540 707-7260163
251 Ventura Rd, Port Hueneme, CA 93041 805-2718141
Eureka, CA
Mentions for Andrew J Tasker
Publications & IP owners
Us Patents
Fused Cycloheptane And Fused Azacycloheptane Compounds And Their Methods Of Use
US Patent:
6514964, Feb 4, 2003
Filed:
Sep 26, 2000
Appl. No.:
09/671025
Inventors:
Zhidong Chen - Thousand Oaks CA
Celia Dominguez - Thousands Oaks CA
Nianhe Han - Thousand Oaks CA
Ofir A. Moreno - Del Mar CA
Melvin C. Rutledge - Westlake Village CA
Andrew S. Tasker - Simi Valley CA
Celia Dominguez - Thousands Oaks CA
Nianhe Han - Thousand Oaks CA
Ofir A. Moreno - Del Mar CA
Melvin C. Rutledge - Westlake Village CA
Andrew S. Tasker - Simi Valley CA
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07D22316
US Classification:
51421206, 51421207, 51421301, 540521, 540522, 540523, 540593
Abstract:
The invention comprises novel compounds that are effective in the prophylaxis and treatment of diseases, such as integrin receptors mediated diseases, in particular, diseases or conditions mediated by integrin receptors, such as , , and the like. The invention encompasses novel compounds, pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of such diseases and disorders. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
Substituted Alkylamine Derivatives And Methods Of Use
US Patent:
6995162, Feb 7, 2006
Filed:
Jan 10, 2002
Appl. No.:
10/046681
Inventors:
Guoqing Chen - Thousand Oaks CA, US
Jeffrey Adams - Thousand Oaks CA, US
Jean Bemis - Arlington MA, US
Shon Booker - Newbury Park CA, US
Guolin Cai - Thousand Oaks CA, US
Lucian Di Pietro - Gloucester MA, US
Celia Dominguez - Thousand Oaks CA, US
Daniel Elbaum - Newton MA, US
Julie Germain - Somerville MA, US
Stephanie Geuns-Meyer - Medford MA, US
Michael Handley - Ventura CA, US
Qi Huang - Moorpark CA, US
Joseph L. Kim - Wayland MA, US
Alexander Kiselyov - Jersey City NJ, US
Xiaohu Ouyang - Flushing NY, US
Vinod F. Patel - Acton MA, US
Leon M. Smith - Somerset NJ, US
Markian Stec - Filmore CA, US
Andrew Tasker - Simi Valley CA, US
Ning Xi - Thousand Oaks CA, US
Shimin Xu - Newbury Park CA, US
Chester Chenguang Yuan - Newbury Park CA, US
Michael Croghan - Ventura CA, US
Jeffrey Adams - Thousand Oaks CA, US
Jean Bemis - Arlington MA, US
Shon Booker - Newbury Park CA, US
Guolin Cai - Thousand Oaks CA, US
Lucian Di Pietro - Gloucester MA, US
Celia Dominguez - Thousand Oaks CA, US
Daniel Elbaum - Newton MA, US
Julie Germain - Somerville MA, US
Stephanie Geuns-Meyer - Medford MA, US
Michael Handley - Ventura CA, US
Qi Huang - Moorpark CA, US
Joseph L. Kim - Wayland MA, US
Alexander Kiselyov - Jersey City NJ, US
Xiaohu Ouyang - Flushing NY, US
Vinod F. Patel - Acton MA, US
Leon M. Smith - Somerset NJ, US
Markian Stec - Filmore CA, US
Andrew Tasker - Simi Valley CA, US
Ning Xi - Thousand Oaks CA, US
Shimin Xu - Newbury Park CA, US
Chester Chenguang Yuan - Newbury Park CA, US
Michael Croghan - Ventura CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/435
C07D 213/82
C07D 213/82
US Classification:
514256, 514300, 514314, 514333, 514336, 514337, 544333, 546113, 546175, 546256, 546262, 5462717, 5462821, 5462827
Abstract:
Selected heterocyclic compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
Substituted Amine Derivatives And Methods Of Use
US Patent:
7105682, Sep 12, 2006
Filed:
Jan 10, 2002
Appl. No.:
10/046622
Inventors:
Guoqing Chen - Thousand Oaks CA, US
Jeffrey Adams - Thousand Oaks CA, US
Jean Bemis - Arlington MA, US
Lucian Di Pietro - Gloucester MA, US
Celia Dominguez - Thousand Oaks CA, US
Daniel Elbaum - Newton MA, US
Julie Germain - Somerville MA, US
Qi Huang - Moorpark CA, US
Joseph L. Kim - Wayland MA, US
Xiaohu Ouyang - Flushing NY, US
Vinod F. Patel - Acton MA, US
Leon M. Smith - Sommerset NJ, US
Andrew Tasker - Simi Valley CA, US
Ning Xi - Thousand Oaks CA, US
Shimin Xu - Newbury Park CA, US
Chester Chenguang Yuan - Newbury Park CA, US
Michael Croghan - Ventura CA, US
Jeffrey Adams - Thousand Oaks CA, US
Jean Bemis - Arlington MA, US
Lucian Di Pietro - Gloucester MA, US
Celia Dominguez - Thousand Oaks CA, US
Daniel Elbaum - Newton MA, US
Julie Germain - Somerville MA, US
Qi Huang - Moorpark CA, US
Joseph L. Kim - Wayland MA, US
Xiaohu Ouyang - Flushing NY, US
Vinod F. Patel - Acton MA, US
Leon M. Smith - Sommerset NJ, US
Andrew Tasker - Simi Valley CA, US
Ning Xi - Thousand Oaks CA, US
Shimin Xu - Newbury Park CA, US
Chester Chenguang Yuan - Newbury Park CA, US
Michael Croghan - Ventura CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07D 401/02
A61K 31/44
A61K 31/44
US Classification:
5462771, 546194, 546199, 5462737, 5462757, 544253, 514255, 514318, 514338, 514339
Abstract:
Selected amines are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
Substituted Anthranilic Amide Derivatives And Methods Of Use
US Patent:
7307088, Dec 11, 2007
Filed:
Jul 8, 2003
Appl. No.:
10/615809
Inventors:
Qi Huang - Moorpark CA, US
Guoqing Chen - Thousand Oaks CA, US
Aiwen Li - Westlake Village CA, US
Babak Riahi - Woodland Hills CA, US
Andrew Tasker - Simi Valley CA, US
Kevin Yang - San Gabriel CA, US
Chester Chenguang Yuan - Newbury Park CA, US
Guoqing Chen - Thousand Oaks CA, US
Aiwen Li - Westlake Village CA, US
Babak Riahi - Woodland Hills CA, US
Andrew Tasker - Simi Valley CA, US
Kevin Yang - San Gabriel CA, US
Chester Chenguang Yuan - Newbury Park CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/4709
A61K 31/4725
A61K 31/404
A61K 31/357
C07D 217/04
C07D 215/38
C07D 209/08
C07D 319/18
A61K 31/4725
A61K 31/404
A61K 31/357
C07D 217/04
C07D 215/38
C07D 209/08
C07D 319/18
US Classification:
514310, 514311, 514414, 514415, 514456, 546143, 546159, 548504, 549362
Abstract:
Selected compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
Substituted 2,3-Dihydro-1H-Isoindol-1-One Derivatives And Methods Of Use
US Patent:
7320992, Jan 22, 2008
Filed:
Aug 24, 2004
Appl. No.:
10/926238
Inventors:
Christopher Tegley - Thousand Oaks CA, US
Jeffrey A. Adams - Thousand Oaks CA, US
Michael Croghan - Thousand Oaks CA, US
Daniel Elbaum - Newton MA, US
Julie Germain - Medford MA, US
Gregory J. Habgood - Merrimac MA, US
Scott Harried - Woodland Hills CA, US
Aiwen Li - Westlake Village CA, US
Nobuko Nishimura - West Hills CA, US
Rana Nomak - Istanbul, TR
Andrew Tasker - Simi Valley CA, US
Kevin Yang - San Gabriel CA, US
Jeffrey A. Adams - Thousand Oaks CA, US
Michael Croghan - Thousand Oaks CA, US
Daniel Elbaum - Newton MA, US
Julie Germain - Medford MA, US
Gregory J. Habgood - Merrimac MA, US
Scott Harried - Woodland Hills CA, US
Aiwen Li - Westlake Village CA, US
Nobuko Nishimura - West Hills CA, US
Rana Nomak - Istanbul, TR
Andrew Tasker - Simi Valley CA, US
Kevin Yang - San Gabriel CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/4439
C07D 401/12
C07D 401/12
US Classification:
514339, 5462771, 546152, 546139, 546113, 548472, 544111, 514416, 514314, 514307, 514300, 5142315
Abstract:
Selected compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
Thiadiazole Compounds And Methods Of Use
US Patent:
7354944, Apr 8, 2008
Filed:
Oct 18, 2005
Appl. No.:
11/251846
Inventors:
Qingping Zeng - Thousand Oaks CA, US
Guomin Yao - Newbury Park CA, US
George Erich Wohlhieter - Lake Balboa CA, US
Vellarkad N. Viswanadhan - Thousand Oaks CA, US
Andrew Tasker - Simi Valley CA, US
James Thomas Rider - Woodland Hills CA, US
Holger Monenschein - Camarillo CA, US
Celia Dominguez - Thousand Oaks CA, US
Matthew Paul Bourbeau - Woodland Hills CA, US
Guomin Yao - Newbury Park CA, US
George Erich Wohlhieter - Lake Balboa CA, US
Vellarkad N. Viswanadhan - Thousand Oaks CA, US
Andrew Tasker - Simi Valley CA, US
James Thomas Rider - Woodland Hills CA, US
Holger Monenschein - Camarillo CA, US
Celia Dominguez - Thousand Oaks CA, US
Matthew Paul Bourbeau - Woodland Hills CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/433
A61K 31/4725
A61K 31/416
A61K 31/4162
C07D 285/135
C07D 217/02
C07D 405/04
C07D 417/04
C07D 217/00
A61K 31/4725
A61K 31/416
A61K 31/4162
C07D 285/135
C07D 217/02
C07D 405/04
C07D 417/04
C07D 217/00
US Classification:
514363, 514405, 514407, 514307, 548138, 548137, 5483611, 5483641, 546113, 546139
Abstract:
The invention relates to thiadiazole compounds useful for treating diseases mediated by protein kinase B (PKB). The invention also relates to the therapeutic use of such thiadiazole compounds and compositions thereof in treating disease states associated with abnormal cell growth, cancer, inflammation, and metabolic disorders.
Substituted Amine Derivatives And Methods Of Use
US Patent:
7514564, Apr 7, 2009
Filed:
May 2, 2006
Appl. No.:
11/417329
Inventors:
Guoqing Chen - Thousand Oaks CA, US
Jeffrey Adams - Thousand Oaks CA, US
Jean Bemis - Arlington MA, US
Lucian Di Pietro - Gloucester MA, US
Celia Dominguez - Thousand Oaks CA, US
Daniel Elbaum - Newton MA, US
Julie Germain - Somerville MA, US
Qi Huang - Moorpark CA, US
Joseph L. Kim - Wayland MA, US
Xiaohu Ouyang - Flushing NY, US
Vinod F. Patel - Acton MA, US
Leon M. Smith - Somerset NJ, US
Andrew Tasker - Simi Valley CA, US
Ning Xi - Thousand Oaks CA, US
Shimin Xu - Newbury Park CA, US
Chester Chenguang Yuan - Newbury Park CA, US
Michael Croghan - Ventura CA, US
Jeffrey Adams - Thousand Oaks CA, US
Jean Bemis - Arlington MA, US
Lucian Di Pietro - Gloucester MA, US
Celia Dominguez - Thousand Oaks CA, US
Daniel Elbaum - Newton MA, US
Julie Germain - Somerville MA, US
Qi Huang - Moorpark CA, US
Joseph L. Kim - Wayland MA, US
Xiaohu Ouyang - Flushing NY, US
Vinod F. Patel - Acton MA, US
Leon M. Smith - Somerset NJ, US
Andrew Tasker - Simi Valley CA, US
Ning Xi - Thousand Oaks CA, US
Shimin Xu - Newbury Park CA, US
Chester Chenguang Yuan - Newbury Park CA, US
Michael Croghan - Ventura CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07D 211/94
C07D 211/98
A61K 31/44
C07D 211/98
A61K 31/44
US Classification:
546304, 546290, 546296, 546297, 546300, 546301, 546302, 546303, 546312, 514345, 514349, 514352
Abstract:
Selected amines are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
Thiazole Compounds And Methods Of Use
US Patent:
7514566, Apr 7, 2009
Filed:
Jan 11, 2007
Appl. No.:
11/652728
Inventors:
Qingping Zeng - Thousand Oaks CA, US
John G. Allen - Newbury Park CA, US
Matthew P. Bourbeau - Woodland Hills CA, US
Celia Dominguez - Los Angeles CA, US
Christopher H. Fotsch - Thousand Oaks CA, US
Nianhe Han - Thousand Oaks CA, US
Xin Huang - Roslindale MA, US
Matthew R. Lee - Calabasas CA, US
Aiwen Li - Westlake Village CA, US
Qingyian Liu - Camarillo CA, US
James T. Rider - Camarillo CA, US
Seifu Tadesse - Simi Valley CA, US
Andrew S. Tasker - Simi Valley CA, US
Vellarkad N. Viswanadhan - Thousand Oaks CA, US
Xianghong Wang - Moorpark CA, US
Kurt E. Weiler - Thousand Oaks CA, US
George E. Wohlhieter - Lake Balboa CA, US
Guomin Yao - Newbury Park CA, US
Chester Chenguang Yuan - Newbury Park CA, US
John G. Allen - Newbury Park CA, US
Matthew P. Bourbeau - Woodland Hills CA, US
Celia Dominguez - Los Angeles CA, US
Christopher H. Fotsch - Thousand Oaks CA, US
Nianhe Han - Thousand Oaks CA, US
Xin Huang - Roslindale MA, US
Matthew R. Lee - Calabasas CA, US
Aiwen Li - Westlake Village CA, US
Qingyian Liu - Camarillo CA, US
James T. Rider - Camarillo CA, US
Seifu Tadesse - Simi Valley CA, US
Andrew S. Tasker - Simi Valley CA, US
Vellarkad N. Viswanadhan - Thousand Oaks CA, US
Xianghong Wang - Moorpark CA, US
Kurt E. Weiler - Thousand Oaks CA, US
George E. Wohlhieter - Lake Balboa CA, US
Guomin Yao - Newbury Park CA, US
Chester Chenguang Yuan - Newbury Park CA, US
Assignee:
Amgen, Inc. - Thousand Oaks CA
International Classification:
A61K 31/425
C07D 277/00
C07D 277/00
US Classification:
548198, 514370
Abstract:
The invention relates to thiazole compounds of Formula I and Formula II and compositions thereof useful for treating diseases mediated by protein kinase B (PKB) where the variables have the definitions provided herein.
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.